Why Is Exparel So Hard to Find? [Explained for 2026]

If you've heard about Exparel and are wondering why you can't simply call your pharmacy and request it — you're not alone. Exparel (bupivacaine liposome injectable suspension) is a unique surgical pain medication that works very differently from the drugs most people are familiar with. It's not dispensed at your local CVS, Walgreens, or independent pharmacy. Instead, it's administered by a healthcare provider — your surgeon or anesthesiologist — directly at the surgical site during or after your procedure.

So when patients say they can't "find" Exparel, what they usually mean is one of several things: their surgeon didn't mention it, their hospital doesn't carry it on formulary, their insurance won't cover it, or they're trying to understand if they're a candidate for it. This guide breaks down each of those barriers and what you can do about them.

What Is Exparel and Why Is It Different From Other Pain Medications?

Exparel is an extended-release formulation of bupivacaine, a well-known local anesthetic. What makes Exparel special is its DepoFoam delivery system — bupivacaine is encapsulated inside multivesicular liposomes (tiny fat-based particles arranged in a honeycomb structure). When injected at a surgical site or near a nerve, these particles slowly break down and release bupivacaine over a period of up to 72 hours.

Standard bupivacaine or lidocaine wears off in hours. Exparel can provide meaningful postoperative pain relief for up to three days from a single injection — without opioids. It was FDA-approved in October 2011 for surgical site infiltration and in April 2018 for interscalene brachial plexus nerve blocks (shoulder surgery). It's also approved for sciatic and adductor canal nerve blocks in adults.

Reason #1: It's Only Available in Hospital and Surgical Settings

The most common reason patients can't "find" Exparel is straightforward: it's not a take-home medication. Exparel is administered by a surgeon, anesthesiologist, or CRNA (Certified Registered Nurse Anesthetist) in a hospital, outpatient surgical center, or ambulatory surgery center. It's injected once, directly into the surgical site or near a nerve, and then it does its job over the following days.

This means the question isn't "Which pharmacy has Exparel?" but rather "Does my surgical team use Exparel, and does my facility have it on formulary?" Those are very different questions — and they have very different answers depending on where you're having surgery.

Reason #2: Hospital Formulary Restrictions

A hospital formulary is the list of drugs that a hospital or health system has approved for use and stocks in its pharmacy. Not every medication makes the cut — and Exparel is one that sometimes gets left off or restricted.

Why? Cost. A single 20 mL vial of Exparel has an average wholesale price of roughly $378–$444, compared to just $2–$8 for a standard bupivacaine vial. When a hospital performs thousands of surgeries a year, using Exparel in even 10% of cases adds hundreds of thousands of dollars in drug costs annually. Hospital pharmacy and therapeutics (P&T) committees carefully weigh whether the clinical benefit justifies that cost — and not all of them conclude that it does for every procedure type.

Some hospitals have Exparel on formulary for specific procedures only (such as total knee replacement or shoulder surgery) and not others. Others restrict it to certain surgeons or departments. And some smaller facilities may not stock it at all.

Reason #3: Insurance Coverage Is Complicated

Unlike most medications that you pick up at a pharmacy and bill through your prescription drug (Part D or pharmacy) insurance benefit, Exparel is typically billed through your medical insurance benefit — because it's administered by a provider in a clinical setting.

Coverage varies significantly by insurer and plan. Medicare Part D does not typically cover Exparel, but Medicare Part B or the facility's overall reimbursement may apply depending on the procedure and setting. Many commercial insurers cover it for certain procedures (such as total joint replacement or shoulder surgery) but may require prior authorization. Some plans deny it outright as experimental or not medically necessary for certain indications.

Reason #4: Your Surgeon May Not Routinely Use It

Even when Exparel is on the hospital formulary and insurance covers it, many surgeons simply don't use it as their default. Some prefer continuous peripheral nerve block catheters, which can also provide multi-day pain relief through different means. Others use multimodal analgesia protocols — combining acetaminophen, NSAIDs, and short-acting local anesthetics — that they've found equally effective.

The evidence on Exparel is also debated in medical literature. While some studies show significant reductions in opioid use and postoperative pain scores, others have found limited advantage over plain bupivacaine in certain settings. This ongoing clinical debate means that some physicians are enthusiastic adopters while others remain skeptical.

What Can Patients Do?

If you want Exparel as part of your surgical pain plan, you have options:

• Ask your surgeon directly. At your preoperative appointment, simply ask: "Do you use Exparel for this procedure? If not, why not, and what is your pain management plan?"
• Ask about the anesthesia plan. Sometimes the anesthesiologist (not the surgeon) makes the decision about which local anesthetic to use. Request a presurgical meeting with your anesthesia team.
• Check if your facility uses Exparel. You can call the hospital or surgical center's pharmacy and ask if bupivacaine liposome (Exparel) is on their formulary for your procedure type.
• Check insurance prior authorization requirements. Call your insurance company and ask whether Exparel is covered for your specific CPT procedure code, and whether prior authorization is required.
• Ask about the NOPAIN Act. The Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act authorized Medicare to make separate payments for non-opioid pain management drugs like Exparel used in outpatient settings — ask if this applies to your procedure.

Is There a National Shortage of Exparel?

As of 2026, Exparel does not appear on the FDA's active drug shortage database. However, individual hospitals or surgical centers may have access issues due to formulary decisions, purchasing contract changes, or cost-containment policies — rather than a true manufacturing shortage. Some hospitals periodically remove Exparel from their formulary or restrict its use to specific procedures to manage drug budgets.

If you're having trouble getting information about Exparel availability at your facility, the most direct path is contacting your surgical team and your hospital's pharmacy department.

How medfinder Can Help With Your Pain Management Journey

While Exparel itself is administered in the surgical setting, your postoperative care may involve other oral medications — pain relievers, anti-inflammatories, and more — that you'll need to fill at a pharmacy. medfinder is a paid service that calls pharmacies in your area to find which ones have your medications in stock, saving you the frustrating process of calling multiple pharmacies yourself. If you're navigating postoperative prescriptions or any other medication, medfinder can help locate what you need near you.

For more detail on how to access Exparel, see our guide on how to find Exparel in stock near you.

You may also want to read our complete overview: What Is Exparel? Uses, Dosage, and What You Need to Know in 2026.